Target intelligence / Profile preview

KRAB-A domain containing 1 (KRBA1)

Target
KRBA1
Molecular classification
Transcription factor, Zinc finger protein, KRAB domain-containing protein
01

Overview

KRBA1 (KRAB-A domain containing 1) is a human protein containing a KRAB (Kruppel-associated box) domain and multiple C2H2-type zinc finger motifs, characteristic of KRAB domain zinc finger transcription factors[1][2][3]. The KRAB domain acts as a strong transcriptional repressor by recruiting corepressor proteins such as KAP-1/TRIM28, which in turn assemble chromatin-modifying complexes to silence gene expression[1][2][3]. KRAB domain proteins are vertebrate-specific and function in regulation of transcription, chromatin structure, cell proliferation, differentiation, and apoptosis[1][2]. While KRAB-ZFPs play significant regulatory roles and are implicated in cancer by virtue of their involvement in cell cycle and apoptosis[1][2], there is no direct evidence that KRBA1, or the ambiguous "KRAB domain containing 3," is a validated therapeutic drug target, nor is its involvement with pharmacological agents or clinical biomarkers documented.

Other names
KRBA1KRAB-A domain containing 1KIAA1862protein KRBA1
02

Mechanism of action

No mechanism of action described for drugs targeting KRBA1/KRABD3; general KRAB-ZFP mechanism involves transcriptional repression via corepressor KAP-1/TRIM28 recruitment[1][2][3]

03

Biological functions

Transcriptional repressionChromatin remodelingRegulation of gene expressionCell proliferationCell differentiationApoptosis
04

Disease associations

Cancer (general role attributed to KRAB-ZFPs, but specific disease involvement of KRBA1 or "KRAB domain containing 3" is not established)

Beyond the preview

Go deeper on KRAB-A domain containing 1 (KRBA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KRAB-A domain containing 1 (KRBA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call